Jpmorgan Chase & CO Pmv Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 200,545 shares of PMVP stock, worth $328,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,545

Previous 119,269 68.15%

Holding current value

$328,893

Previous $202,000 60.4%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.51 - $2.21 $122,726 - $179,619	81,276 Added 68.15%	200,545 $324,000
Q1 2024 May 10, 2024	SELL	$1.51 - $3.12 $5.75 Million - $11.9 Million	-3,811,071 Reduced 96.97%	119,269 $202,000
Q4 2023 Feb 12, 2024	SELL	$1.23 - $6.6 $127,158 - $682,314	-103,381 Reduced 2.56%	3,930,340 $12.2 Million
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.93 $251,115 - $373,122	-41,783 Reduced 1.03%	4,033,721 $24.8 Million
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $286,122 - $455,327	72,620 Added 1.81%	4,075,504 $25.5 Million
Q1 2023 May 18, 2023	BUY	$4.77 - $9.16 $209,732 - $402,756	43,969 Added 1.11%	4,002,884 $19.1 Million
Q1 2023 May 11, 2023	SELL	$4.77 - $9.16 $656,523 - $1.26 Million	-137,636 Reduced 3.36%	3,958,915 $18.9 Million
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $4.98 Million - $7.89 Million	-609,548 Reduced 12.95%	4,096,551 $35.6 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $2.43 Million - $3.66 Million	-213,224 Reduced 4.33%	4,706,099 $56 Million
Q2 2022 Aug 11, 2022	BUY	$9.23 - $22.43 $15.8 Million - $38.4 Million	1,713,836 Added 53.47%	4,919,323 $70.1 Million
Q1 2022 May 11, 2022	BUY	$14.86 - $23.55 $568,617 - $901,140	38,265 Added 1.21%	3,205,487 $66.7 Million
Q4 2021 Feb 10, 2022	BUY	$19.99 - $30.24 $27.2 Million - $41.1 Million	1,360,130 Added 75.27%	3,167,222 $73.2 Million
Q3 2021 Nov 12, 2021	BUY	$26.84 - $36.58 $48.5 Million - $66.1 Million	1,807,092 New	1,807,092 $53.9 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

43.4M

Call Options Held

500

Put Options Held

100

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $74.8M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Pmv Pharmaceuticals, Inc. Transaction History